LungMAP || A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)

A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)

Learn more:
http://www.clinicaltrials.gov/ct2/show/NCT03851445

Protocol Number

C-361

Phase

Management Group

Oncology Network

Oncology Group

Lung Oncology Group

Disease Sites

Lung

Sponsor Protocol

LungMAP

Principal Investigator

Ioana Bonta

Scope

National

Participating Institutions

Atlanta Cancer Care - Atlanta
Atlanta Cancer Care - Cumming
Atlanta Cancer Care - Stockbridge
Georgia Cancer Specialists - Athens
Georgia Cancer Specialists - Blairsville
Georgia Cancer Specialists - Canton
Georgia Cancer Specialists - Decatur
Georgia Cancer Specialists - Macon
Georgia Cancer Specialists - Marietta
Georgia Cancer Specialists - Northside
Suburban Hematology Oncology Associates - Duluth
Suburban Hematology Oncology Associates - Lawrenceville

Find Open Clinical Trials

A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)

Want to learn more?